Categories: Genetic diseases, Rare diseases, Neuronal diseases, Bone diseases, Metabolic diseases, Fetal diseases
49OMIM, 10Disease Ontology, 11diseasecard, 45NIH Rare Diseases, 23Genetics Home Reference, 12DISEASES, 51Orphanet, 67UniProtKB/Swiss-Prot, 36MeSH, 24GTR, 65UMLS, 22GeneTests, 27ICD10, 42NCIt, 59SNOMED-CT, 66UMLS via Orphanet, 28ICD10 via Orphanet, 37MESH via Orphanet, 34MedGen, 61The Human Phenotype Ontology
See all MalaCards sources
Aliases & Descriptions for Aspartylglucosaminuria:
Orphanet epidemiological data:51
Inheritance: Autosomal recessive; Age of onset: Childhood
Inheritance: autosomal recessive inheritance
Global: Genetic diseases, Rare diseases, Metabolic diseases, Fetal diseases
Anatomical: Neuronal diseases, Bone diseases
ICD10: 28 27
Rare neurological diseases
Rare bone diseases
Inborn errors of metabolism
Developmental anomalies during embryogenesis
NIH Rare Diseases:45 Aspartylglycosaminuria is a very rare lysosomal storage disease that causes a progressive decline in mental functioning. infants with aspartylglycosaminuria appear healthy at birth with signs and symptoms beginning around the age of 2 or 3. major symptoms may include coarse facial features, spine and eye deformities, behavior problems, and intellectual disability. symptoms result from a deficiency in an enzyme called aspartylglycosaminidase, which leads to an accumulation of a protein called glycoasparagine in the body tissues and increased excretion of this protein in the urine. aspartylglycosaminuria is inherited in an autosomal recessive fashion and caused by mutations in the aga gene. it is commonly seen in individuals of finnish decent. last updated: 8/17/2011
MalaCards based summary: Aspartylglucosaminuria, also known as aspartylglycosaminuria, is related to serine deficiency and crohn's disease, and has symptoms including large face, cognitive impairment and abnormality of movement. An important gene associated with Aspartylglucosaminuria is AGA (Aspartylglucosaminidase), and among its related pathways is Lysosome. Affiliated tissues include bone, skin and eye, and related mouse phenotypes are liver/biliary system and renal/urinary system.
UniProtKB/Swiss-Prot:67 Aspartylglucosaminuria: An inborn lysosomal storage disease causing excess accumulation of glycoasparagine in the body tissues and its increased excretion in urine. Clinical features include mild to severe mental retardation manifesting from the age of two, coarse facial features and mild connective tissue abnormalities.
Genetics Home Reference:23 Aspartylglucosaminuria is a condition that causes a progressive decline in mental functioning.
OMIM:49 Aspartylglucosaminuria is a severe autosomal recessive lysosomal storage disorder that involves the central nervous... (208400) more...
Wikipedia:68 Aspartylglucosaminuria (AGU) is an inherited disease that is characterized by a decline in mental... more...
Symptoms by clinical synopsis from OMIM:208400
Clinical features from OMIM:208400
Symptoms:51 (show all 41)
HPO human phenotypes related to Aspartylglucosaminuria:(show all 73)
Drugs for Aspartylglucosaminuria (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):(show top 50) (show all 68)
Interventional clinical trials:
Search NIH Clinical Center for Aspartylglucosaminuria
MalaCards organs/tissues related to Aspartylglucosaminuria:33
Bone, Skin, Eye, Liver, Tongue, Bone marrow, Breast
MGI Mouse Phenotypes related to Aspartylglucosaminuria:38
Articles related to Aspartylglucosaminuria:(show top 50) (show all 85)
UniProtKB/Swiss-Prot genetic disease variations for Aspartylglucosaminuria:67 (show all 12)
Clinvar genetic disease variations for Aspartylglucosaminuria:5 (show all 27)
Search GEO for disease gene expression data for Aspartylglucosaminuria.
28ICD10 via Orphanet
37MESH via Orphanet
50OMIM via Orphanet
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
66UMLS via Orphanet